Literature DB >> 14604961

Functional differences between hepcidin 1 and 2 in transgenic mice.

Dan-Qing Lou1, Gaël Nicolas, Jeanne-Claire Lesbordes, Lydie Viatte, Gisèle Grimber, Marie-France Szajnert, Axel Kahn, Sophie Vaulont.   

Abstract

Hepcidin is a 25-amino acid peptide involved in iron homeostasis in mice and humans. It is produced in the liver from a larger precursor, and it is detectable in blood and urine. In contrast to the human genome, which contains only one copy of the gene, the mouse genome contains 2 highly similar hepcidin genes, hepc1 and hepc2, which are, however, considerably divergent at the level of the corresponding mature 25-amino acid peptide. This striking observation led us to ask whether hepc1 and hepc2 performed the same biologic activity with regard to iron metabolism in the mouse. We recently described the severe iron-deficient anemia phenotype in transgenic mice overexpressing hepc1 in the liver. Here we report that, in contrast to the hepc1-transgenic mice, none of the 7 founder hepc2-transgenic animals suffered from anemia. They all developed normally with hematologic parameters similar to the nontransgenic littermates. Hepc2 transgenic mRNA level was found to be very high for all lines compared with the level of hepc1 transgene mRNA necessary to produce severe anemia. These data provide evidence that hepc2 does not act on iron metabolism like hepc1 and give clues for the identification of amino acids important for the iron-regulatory action of the mature 25-amino acid peptide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604961     DOI: 10.1182/blood-2003-07-2524

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens.

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Vivekanand Datta; Xavier Lauth; Randall S Johnson; Victor Nizet
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

2.  Inductively coupled mass spectrometry analysis of biometals in conditional Hamp1 and Hamp1 and Hamp2 transgenic mouse models.

Authors:  S Lu; J Seravalli; D Harrison-Findik
Journal:  Transgenic Res       Date:  2015-04-23       Impact factor: 2.788

3.  Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.

Authors:  Cindy N Roy; Howard H Mak; Imo Akpan; Grigoriy Losyev; David Zurakowski; Nancy C Andrews
Journal:  Blood       Date:  2007-01-11       Impact factor: 22.113

4.  Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.

Authors:  Kelly A Fader; Rance Nault; Mathew P Kirby; Gena Markous; Jason Matthews; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2017-02-16       Impact factor: 4.219

Review 5.  Hepcidin and iron regulation, 10 years later.

Authors:  Tomas Ganz
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

6.  First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin.

Authors:  D F Wallace; L Summerville; P E Lusby; V N Subramaniam
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

7.  Urine proteome analysis in murine nephrotoxic serum nephritis.

Authors:  Scott E Wenderfer; William P Dubinsky; Mayra Hernandez-Sanabria; Michael C Braun
Journal:  Am J Nephrol       Date:  2009-09-24       Impact factor: 3.754

8.  In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation.

Authors:  Lydie Viatte; Hermann-Josef Gröne; Matthias W Hentze; Bruno Galy
Journal:  J Mol Med (Berl)       Date:  2009-06-17       Impact factor: 4.599

9.  Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration.

Authors:  Guo-yang Zhao; Dong-hua Di; Bo Wang; Xi Huang; You-jia Xu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

10.  The hepcidin-binding site on ferroportin is evolutionarily conserved.

Authors:  Ivana De Domenico; Elizabeta Nemeth; Jenifer M Nelson; John D Phillips; Richard S Ajioka; Michael S Kay; James P Kushner; Tomas Ganz; Diane M Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.